OCT-1

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:55:42 GMT 2025` Edited by `admin` on `Mon Mar 31 22:55:42 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	ONY583280Z
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OCT-1

Common Name

English

HOCT1

Preferred Name

English

OCT1

Common Name

English

SLC22A1

Common Name

English

HUMAN ORGANIC CATION TRANSPORTER 1

Common Name

English

SOLUTE CARRIER FAMILY 22 MEMBER 1

Common Name

English

ORGANIC CATION TRANSPORTER 1

Common Name

English

Classification Tree Code System Code

UCSF-FDA TRANSPORTAL

SLC22A1

Created by admin on Mon Mar 31 22:55:42 GMT 2025 , Edited by admin on Mon Mar 31 22:55:42 GMT 2025

Code System Code Type Description

FDA UNII

ONY583280Z

Created by admin on Mon Mar 31 22:55:42 GMT 2025 , Edited by admin on Mon Mar 31 22:55:42 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_71

Related Record Type Details


					884KT10YB7

RANITIDINE

INHIBITOR -> TRANSPORTER


					OSP71S83EU

LORLATINIB

INHIBITOR -> TRANSPORTER


					8110R61I4U

AMISULPRIDE

SUBSTRATE -> TRANSPORTER


					W8O17SJF3T

MEMANTINE

INHIBITOR -> TRANSPORTER


					TG537D343B

DESIPRAMINE

SUBSTRATE -> TRANSPORTER


					673LC5J4LQ

PENTAMIDINE

INHIBITOR -> TRANSPORTER


					BF4C9Z1J53

AMANTADINE

INHIBITOR -> TRANSPORTER


					2Z3E1OF81V

BUTYLSCOPOLAMINE

INHIBITOR -> TRANSPORTER


					I5Y540LHVR

COCAINE

INHIBITOR -> TRANSPORTER


					668Z8C33LU

REPAGLINIDE

INHIBITOR -> TRANSPORTER


					5AV7G7EIEE

TETRAETHYLAMMONIUM

INHIBITOR -> TRANSPORTER


					8237F3U7EH

RUCAPARIB

INHIBITOR -> TRANSPORTER

Interaction Type:

MODERATE


					X4OV71U42S

PIOGLITAZONE

INHIBITOR -> TRANSPORTER


					BRU7LG9LNL

PSEUDOISOCYANINE IODIDE

INHIBITOR -> TRANSPORTER


					44RAL3456C

METHAMPHETAMINE

INHIBITOR -> TRANSPORTER

Qualification:

IC50

Amount:


					690G0D6V8H

KETAMINE

INHIBITOR -> TRANSPORTER


					W9YXS298BM

TUBOCURARINE

INHIBITOR -> TRANSPORTER


					G22N65IL3O

PACRITINIB

INHIBITOR -> TRANSPORTER

Qualification:

IC50

Amount:


					2CN60TN6ZS

Lurbinectedin

INHIBITOR -> TRANSPORTER


					08GH1YF0RA

FURAMIDINE

INHIBITOR -> TRANSPORTER


					WOH1JD9AR8

Olaparib

INHIBITOR -> TRANSPORTER


					ITX08688JL

QUINIDINE

SUBSTRATE -> TRANSPORTER


					L3JE09KZ2F

SAQUINAVIR

INHIBITOR -> TRANSPORTER


					80061L1WGD

CIMETIDINE

SUBSTRATE -> TRANSPORTER

Amount:


					DD5K7529CE

PHENFORMIN

INHIBITOR -> TRANSPORTER


					4340891KFS

PONATINIB

SUBSTRATE -> TRANSPORTER


					7LBRZUYSHU

BRANEBRUTINIB

INHIBITOR -> TRANSPORTER


					4V9848RS5G

Tirbanibulin

INHIBITOR -> TRANSPORTER

Comments:

The results suggest that KLISYRI has no clinically meaningful effect on the PK of drugs mediated by OCT1

Qualification:

IC50

Amount:


					MN3L5RMN02

CLONIDINE

INHIBITOR -> TRANSPORTER


					ZB6F8MY53V

ETILEFRINE

INHIBITOR -> TRANSPORTER


					J1DOI7UV76

PHENCYCLIDINE

INHIBITOR -> TRANSPORTER


					ITX08688JL

QUINIDINE

INHIBITOR -> TRANSPORTER


					BF4C9Z1J53

AMANTADINE

SUBSTRATE -> TRANSPORTER


					KE1SEN21RM

MIDOMAFETAMINE

INHIBITOR -> TRANSPORTER


					L39WTC366D

PROCAINAMIDE

INHIBITOR -> TRANSPORTER


					X66NSO3N35

THIAMINE

SUBSTRATE -> TRANSPORTER

Amount:


					9100L32L2N

Metformin

INHIBITOR -> TRANSPORTER


					5W6YA9PKKH

INDINAVIR

INHIBITOR -> TRANSPORTER


					80061L1WGD

CIMETIDINE

INHIBITOR -> TRANSPORTER


					1806D8D52K

Amitriptyline

INHIBITOR -> TRANSPORTER


					SX6K58TVWC

GLYBURIDE

INHIBITOR -> TRANSPORTER


					A7V27PHC7A

QUININE

INHIBITOR -> TRANSPORTER


					P9G3CKZ4P5

Ganciclovir

SUBSTRATE -> TRANSPORTER


					X4HES1O11F

ACYCLOVIR

SUBSTRATE -> TRANSPORTER


					W980KJ009P

CORTICOSTERONE

INHIBITOR -> TRANSPORTER


					X4HES1O11F

ACYCLOVIR

SUBSTRATE -> TRANSPORTER


					P9G3CKZ4P5

Ganciclovir

SUBSTRATE -> TRANSPORTER


					5QZO15J2Z8

FAMOTIDINE

SUBSTRATE -> TRANSPORTER

Amount:


					J4T82NDH7E

ERLOTINIB

SUBSTRATE -> TRANSPORTER


					820484N8I3

HISTAMINE

SUBSTRATE -> TRANSPORTER

Amount:


					CJ0O37KU29

VERAPAMIL

INHIBITOR -> TRANSPORTER


					7PY8KH681I

DIZOCILPINE

INHIBITOR -> TRANSPORTER


					LRK3W477YB

N-METHYLPYRIDINIUM CHLORIDE

INHIBITOR -> TRANSPORTER


					H821664NPK

Perampanel

INHIBITOR -> TRANSPORTER

Comments:

Thus, the unbound Cmax is about 0.09 ?M, much lower than 8.5 ?M. Therefore, E2007 is unlikely to inhibit OAT1, OAT3, OCT1 and OCT3 in vivo.

Qualification:

Amount:


					09ERP08I3W

LESINURAD

INHIBITOR -> TRANSPORTER

Comments:

Based on in vitro studies, lesinurad is a weak inhibitor of OATP1B1, OCT1, OAT1, and OAT3.

Interaction Type:

WEAK


					610V23S0JI

DUVELISIB

INHIBITOR -> TRANSPORTER


					333DO1RDJY

Serotonin

SUBSTRATE -> TRANSPORTER

Amount:


					GFO928U8MQ

DISOPYRAMIDE

INHIBITOR -> TRANSPORTER


					4340891KFS

PONATINIB

NON-SUBSTRATE -> TRANSPORTER


					05V02F2KDG

ROSIGLITAZONE

INHIBITOR -> TRANSPORTER


					R60L0SM5BC

MIDAZOLAM

INHIBITOR -> TRANSPORTER


					HO3OGH5D7I

NELFINAVIR

INHIBITOR -> TRANSPORTER


					O3J8G9O825

RITONAVIR

INHIBITOR -> TRANSPORTER


					66D92MGC8M

GILTERITINIB

INHIBITOR -> TRANSPORTER

Qualification:

IC50

Amount:


					7H5Q4J1CM5

SEPANTRONIUM BROMIDE

INHIBITOR -> TRANSPORTER


					RBZ1571X5H

DASATINIB

SUBSTRATE -> TRANSPORTER


					JFENOMOVE6

HUMAN LIVER

TISSUE EXPRESSION->TRANSPORTER

Interaction Type:

INFLUX


					0TTZ664R7Z

PHENOXYBENZAMINE

INHIBITOR -> TRANSPORTER


					884KT10YB7

RANITIDINE

SUBSTRATE -> TRANSPORTER


					9100L32L2N

Metformin

SUBSTRATE -> TRANSPORTER


					04ZR38536J

OXALIPLATIN

SUBSTRATE -> TRANSPORTER


					5QZO15J2Z8

FAMOTIDINE

INHIBITOR -> TRANSPORTER


					8GTS82S83M

DIPHENHYDRAMINE

INHIBITOR -> TRANSPORTER


					UU226QGU97

IMEGLIMIN

INHIBITOR -> TRANSPORTER


					UU226QGU97

IMEGLIMIN

SUBSTRATE -> TRANSPORTER


					9ZOQ3TZI87

SORAFENIB

SUBSTRATE -> TRANSPORTER


					TZ47U051FI

DEXTROAMPHETAMINE

INHIBITOR -> TRANSPORTER


					9647FM7Y3Z

PANOBINOSTAT

INHIBITOR -> TRANSPORTER

Amount:


					AGG2FN16EV

SIMVASTATIN

INHIBITOR -> TRANSPORTER


					F41401512X

Nilotinib

SUBSTRATE -> TRANSPORTER


					N91BDP6H0X

CHOLINE

SUBSTRATE -> TRANSPORTER


					V99T50803M

SUNITINIB

SUBSTRATE -> TRANSPORTER


					VTD58H1Z2X

DOPAMINE

SUBSTRATE -> TRANSPORTER

Amount:


					A7V27PHC7A

QUININE

SUBSTRATE -> TRANSPORTER


					7C0697DR9I

ATROPINE

INHIBITOR -> TRANSPORTER

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL